---
layout: post
title: Elaine Mardis on Cancer in Technology Review
date: 2008-12-24 09:40:50.000000000 -06:00
categories:
- genomics
tags:
- genomics
- health
- Illumina
- PacBio
- science
- wustl
status: publish
type: post
published: true
meta:
  _edit_last: '2'
author:
  login: dd
  email: dooling@gmail.com
  display_name: dd
  first_name: David
  last_name: Dooling
excerpt: !ruby/object:Hpricot::Doc
  options: {}
---
<p><a href="http://genome.wustl.edu/Bio/MardisBIO.cgi">Elaine Mardis</a>, Co-Director of <a href="http://genome.wustl.edu/">The Genome Center</a> has a brief article in the January/February 2009 issue of Technology Review discussing the application of next-generation sequencing technologies to cancer research entitled <a href="http://www.technologyreview.com/biomedicine/21821/">Cancer Genomics: DNA sequencing will transform our understanding of cancer</a>. In the same issue, there is an article that discusses the oncoming <a href="http://www.technologyreview.com/biomedicine/21805/page1/">age of genomics</a>, including its affect on personalized medicine, "third-generation" sequencing technology player <a href="http://www.pacificbiosciences.com/">Pacific Biosciences</a>, and the <a href="http://www.personalgenomes.org/">Personal Genome Project</a>.</p>
